Scholarly Index
Cheol‐Young Park
Kangbuk Samsung Hospital; 12,498 total citations; 356 total publications; best world rank #311
Kangbuk Samsung Hospital
12,498Total citations
356Total publications
58H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Diabetes Treatment and Management | Lifetime | 520 | KR 6 | 98.14 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 691 | KR 8 | 97.79 |
| Diet, Metabolism, and Disease | Lifetime | 668 | KR 17 | 96.99 |
| Biomarkers in Disease Mechanisms | Lifetime | 468 | KR 7 | 87.19 |
| Clusterin in disease pathology | Lifetime | 532 | KR 31 | 60.70 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 574 | KR 39 | 97.44 |
| Diabetes Treatment and Management | 2021-2025 | 428 | KR 11 | 95.46 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 311 | KR 21 | 93.13 |
| Diet, Metabolism, and Disease | 2021-2025 | 322 | KR 22 | 91.73 |
| Diabetes Management and Research | 2021-2025 | 638 | KR 14 | 93.10 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 558 | KR 18 | 90.20 |
| Pancreatic function and diabetes | 2021-2025 | 820 | KR 12 | 88.45 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 606 | KR 28 | 85.30 |
| Pituitary Gland Disorders and Treatments | 2021-2025 | 638 | KR 15 | 87.49 |
| Growth Hormone and Insulin-like Growth Factors | 2021-2025 | 386 | KR 8 | 84.19 |
| Alcohol Consumption and Health Effects | 2021-2025 | 561 | KR 35 | 83.21 |